AI DRIVEN Development
AI-Driven Optimization for
Cytosolic Delivery
Machine learning is used to accelerate TRIDENT™ development, guide design decisions, and improve the prediction of cytosolic delivery and functional activity across payloads and formulations.
SCROLL
Why AI Matters
Cytosolic Delivery Is a Multivariable Problem
Cytosolic delivery depends on multiple interacting biological and physicochemical variables, including particle properties, linker chemistry, payload characteristics, and cellular context. AI-based analysis helps identify which combinations are most likely to improve delivery and functional activity.
Multivariable Complexity
Particle size, surface chemistry, linker design, payload properties, and cell biology all influence cytosolic delivery.
Faster Experimental Learning
Machine learning helps identify patterns across datasets and prioritize the experiments most likely to improve performance.
Better Design Decisions
Computational models can help focus development on the construct features most likely to drive functional outcomes.
How We Use AI
Data-Guided Development for TRIDENT™
AI is integrated into TRIDENT™ platform development to help refine formulation strategy, accelerate iteration cycles, and improve the quality of decision-making across payload classes.
Design Optimization
AI guides design decisions for TRIDENT constructs, including formulation parameters, linker chemistry, and surface modification, based on predicted cytosolic delivery and functional performance.
Structure‑Activity Analysis
Computational analysis links TRIDENT construct properties to uptake, cytosolic delivery, and biological outcomes, helping identify higher-performing formulations more efficiently.
Performance Prediction
Predictive models trained on experimental data estimate which payload-TRIDENT combinations are most likely to achieve functional activity before in vitro testing.
Data Integration
Cross-experiment analysis identifies patterns across payloads, cell lines, and study conditions, strengthening the platform knowledge base with each iteration.
Platform Advantage
Improving Speed, Precision, and Translational Confidence
By integrating machine learning into platform development, Xelcis aims to shorten optimization cycles, improve translational confidence, and accelerate the generation of partner-ready data.
Reduced Iteration Cycles
Fewer rounds of trial-and-error experimentation through data-driven prioritization.
Improved Translational Confidence
Better understanding of which design parameters drive cytosolic delivery and functional outcomes.
Accelerated Partner Readiness
Faster generation of the technical data packages needed for diligence and partnership evaluation.
Why It Matters
A Smarter Path to Platform Development
TRIDENT™ is being developed as a scalable delivery platform across multiple oncology modalities. AI helps make that process more efficient by turning experimental data into better design rules, stronger predictions, and faster decision-making.
This approach is intended to improve how Xelcis evaluates payload compatibility, prioritizes platform opportunities, and builds a stronger data foundation for collaboration.
Long-Term Value
Building a Learning Platform
Each experiment conducted with TRIDENT™ has the potential to strengthen the platform knowledge base. Over time, AI-enabled learning can help improve prediction, accelerate optimization, and expand the strategic value of the platform across programs and partners.